TNFSF10 and neoplasm: These results suggest that TRAIL activates NF-κB signaling for survival and growth, which causes resistance to apoptosis; however, when OSMI-1 is added, NF-κB signaling is inhibited, resulting in the promotion of apoptosis and suppression of tumor growth.